Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00500942 · ClinicalTrials.gov registry record

Pain Quantification and Pain Management in Interventional Radiology (IR)

A clinical trial of Pain, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
374
Enrollment target
1
Study location

NCT00500942: Completed study of Pain, sponsored by M.D. Anderson Cancer Center.

NCT00500942 is a study of Pain that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 374 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (23% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00500942, a study of Pain, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
374 participants
Enrollment target
1
Study location

Study Summary

Primary Objectives: * To measure and record patients' pain levels before, during, and after standard procedures performed in IR. * To compare different procedures to respective pain levels and patient satisfaction (as determined by questionnaire).

Conditions Studied

Interventions

  • BEHAVIORAL Questionnaire

Study Locations (1)

Texas

  • U.T.M.D. Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 374 participants
Start Date 2003-01
Est. Completion 2009-06
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT00500942 record still lists

NCT00500942 is an observational study that tracks outcomes without assigning an intervention. The registered 374 participants enrollment target is mid-sized for trials with a published cap, above the 303-participant average among 374 other Pain trials with a reported enrollment target (23% higher).

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.

NCT00500942 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00500942 about?

NCT00500942 is a clinical study titled "Pain Quantification and Pain Management in Interventional Radiology (IR)". Primary Objectives: * To measure and record patients' pain levels before, during, and after standard procedures performed in IR. * To compare different procedures to respective pain levels and patient satisfaction (as determined by questionnaire).

What is the current status of trial NCT00500942?

This trial is currently completed. The enrollment target is 374 participants. The study started on 2003-01. Estimated completion is 2009-06.

What conditions does trial NCT00500942 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT00500942?

The interventions under investigation include: Questionnaire (BEHAVIORAL).

Who is sponsoring clinical trial NCT00500942?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00500942 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00500942's enrollment target sits among peer trials

374 51st of 374 higher than 324 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03686124 · 375 participants · Phase 1

    ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

  • NCT04059172 · 375 participants · Early Phase 1

    Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management

  • NCT04134923 · 375 participants

    Imaging Biomarkers in Preclinical and Symptomatic AD

  • NCT04569747 · 375 participants · Phase 2

    A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00500942, the US trial registry maintained by the National Library of Medicine. NCT00500942 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.